Cargando…
A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy
BACKGROUND: Doxazosin and its role as an antihypertensive agent have come under recent scrutiny as a result of the early termination of that treatment arm in ALLHAT. It is unclear why the cardiovascular (CV) event rate in this randomized, controlled trial (RCT), especially heart failure, is higher i...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134479/ https://www.ncbi.nlm.nih.gov/pubmed/12097149 http://dx.doi.org/10.1186/1468-6708-3-7 |